Medical decision making in antipsychotic drug choice for schizophrenia

被引：45

作者：

Hamann, J ^{[1
]}

Langer, B ^{[1
]}

Leucht, S ^{[1
]}

Busch, R ^{[1
]}

Kissling, W ^{[1
]}

机构：

[1] Tech Univ Munich, Klin & Poliklin Psyciat & Psychotherapie, Dept Psychiat, D-81675 Munich, Germany

来源：

AMERICAN JOURNAL OF PSYCHIATRY | 2004年 / 161卷 / 07期

关键词：

D O I：

10.1176/appi.ajp.161.7.1301

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Objective: The influence of patient and physician variables on antipsychotic drug choice for patients with schizophrenia was assessed. Method: Interviews with 100 psychiatrists on drug choice for 200 patients suffering from schizophrenia were conducted. Data were analyzed by using multiple logistic regression. Results: Older physicians were up to five times more likely to prescribe first-generation antipsychotics. Patient variables did not influence treatment decisions significantly. Conclusions: There is an urgent need for more research on clinical decision making and quality management.

引用

页码：1301 / 1304

页数：4

共 7 条

[1]

Essock SM, 2002, SCHIZOPHRENIA BULL, V28, P1

[2] Specialty training and the personal use of benzodiazepines by physicians affect their proneness to prescribe tranquilizers [J].